Quanterix Corp (QTRX)

$6.34 -0.35 (-5.23%)
Market Cap 296.15M
Revenue (ttm) 137.42M
Net Income (ttm) -38.53M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -28.04%
Debt to Equity Ratio 0.00
Volume 511,900
Avg Vol 761,152
Day's Range N/A - N/A
Shares Out 46.71M
Stochastic %K 2%
Beta 1.00
Analysts Hold
Price Target $7.33

Company Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Sim...

Industry: Medical Devices
Sector: Healthcare
Phone: 617 301 9400
Address:
Building 1, 900 Middlesex Turnpike, Billerica, United States
IOMASS
IOMASS Jan. 27 at 7:11 PM
$QTRX Interesting trading volume today - down a bit with market but constructive...
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 24 at 12:22 AM
$QTRX Share Price: $6.49 Contract Selected: Aug 21, 2026 $10 Calls Buy Zone: $0.58 – $0.72 Target Zone: $1.06 – $1.29 Potential Upside: 72% ROI Time to Expiration: 209 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Swick02
Swick02 Jan. 23 at 6:56 PM
$QTRX price is back down to where it was before the new CEO announcement. We also learned that revenues and the cash position are both above forecast for year end. Adding more exposure here on this pullback.
0 · Reply
sakuzoh
sakuzoh Jan. 21 at 2:01 PM
$QTRX huge news https://www.stocktitan.net/news/QTRX/quanterix-announces-landmark-jama-study-highlighting-prognostic-sdqbd9t29qvi.html
0 · Reply
IOMASS
IOMASS Jan. 15 at 6:59 PM
$QTRX Don't need an activist at this stage as it appears QTRX is now positioned for growth/enhancing shareholder value but a smart guy entering the picture based on the new changes would help with credibility...
0 · Reply
OMM22
OMM22 Jan. 14 at 7:34 PM
$QTRX ok 👍🏼
0 · Reply
OMM22
OMM22 Jan. 14 at 7:02 PM
$QTRX helloooooooooooooooooooo
0 · Reply
WycklyTrades
WycklyTrades Jan. 13 at 5:33 AM
$QTRX Potential trend reversal with new President/CEO announcement. ($BTU) DCB watch: $NBY $ATEC $INBS
0 · Reply
topstockalerts
topstockalerts Jan. 12 at 9:31 PM
After Hours Top Gainers PT2 $DRCT $BGMS $FBLG $LVLU $QTRX
0 · Reply
sakuzoh
sakuzoh Jan. 12 at 4:37 PM
$QTRX just got into it, new ceo, insider buys, raised guidance. They tick a lot of boxes. Anyone heavy on this stock ?
0 · Reply
Latest News on QTRX
Quanterix Announces Landmark JAMA Study Highlighting Prognostic Value of Multi-Analyte Approach to Blood-Based Alzheimer's Risk Profiling

Jan 21, 2026, 8:33 AM EST - 10 days ago

Quanterix Announces Landmark JAMA Study Highlighting Prognostic Value of Multi-Analyte Approach to Blood-Based Alzheimer's Risk Profiling

Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jan 16, 2026, 4:01 PM EST - 15 days ago

Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026

Jan 8, 2026, 4:30 PM EST - 23 days ago

Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026

Quanterix Announces Landmark Nature Study Redefining Alzheimer's Disease Neuropathology Prevalence

Dec 22, 2025, 7:30 AM EST - 5 weeks ago

Quanterix Announces Landmark Nature Study Redefining Alzheimer's Disease Neuropathology Prevalence

Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth

Nov 20, 2025, 4:15 PM EST - 2 months ago

Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth

Quanterix Announces Landmark Study Demonstrating Dual GFAP/NfL Blood Test Approach for Personalized Multiple Sclerosis Monitoring

Nov 17, 2025, 5:30 PM EST - 2 months ago

Quanterix Announces Landmark Study Demonstrating Dual GFAP/NfL Blood Test Approach for Personalized Multiple Sclerosis Monitoring

Quanterix Corporation (QTRX) Q3 2025 Earnings Call Transcript

Nov 10, 2025, 7:11 PM EST - 2 months ago

Quanterix Corporation (QTRX) Q3 2025 Earnings Call Transcript

Quanterix Releases Financial Results for the Third Quarter of 2025

Nov 10, 2025, 4:01 PM EST - 2 months ago

Quanterix Releases Financial Results for the Third Quarter of 2025

Quanterix To Report Third Quarter 2025 Financial Results on November 10, 2025

Nov 3, 2025, 7:00 AM EST - 3 months ago

Quanterix To Report Third Quarter 2025 Financial Results on November 10, 2025

Quanterix Accelerator Laboratory Awarded Rigorous New York State Clinical Laboratory Permit

Aug 21, 2025, 4:30 PM EDT - 5 months ago

Quanterix Accelerator Laboratory Awarded Rigorous New York State Clinical Laboratory Permit

Quanterix to Present at the Canaccord Genuity 45th Annual Growth Conference

Aug 11, 2025, 7:00 AM EDT - 6 months ago

Quanterix to Present at the Canaccord Genuity 45th Annual Growth Conference

Quanterix Corporation (QTRX) Q2 2025 Earnings Call Transcript

Aug 9, 2025, 2:27 AM EDT - 6 months ago

Quanterix Corporation (QTRX) Q2 2025 Earnings Call Transcript

Quanterix Releases Financial Results for the Second Quarter of 2025

Aug 7, 2025, 4:06 PM EDT - 6 months ago

Quanterix Releases Financial Results for the Second Quarter of 2025

Quanterix To Report Second Quarter 2025 Financial Results on August 7, 2025

Aug 4, 2025, 4:02 PM EDT - 6 months ago

Quanterix To Report Second Quarter 2025 Financial Results on August 7, 2025

Quanterix Announces Cooperation Agreement with Kent Lake Capital

Aug 4, 2025, 9:30 AM EDT - 6 months ago

Quanterix Announces Cooperation Agreement with Kent Lake Capital

Quanterix Launches Novel p-Tau 205 and p-Tau 212 Assays to Advance Alzheimer's Research at AAIC

Jul 28, 2025, 7:00 AM EDT - 6 months ago

Quanterix Launches Novel p-Tau 205 and p-Tau 212 Assays to Advance Alzheimer's Research at AAIC

Quanterix Completes Acquisition of Akoya Biosciences, Creating the First Integrated Platform Capable of Measuring Biomarkers Across the Blood and Tissue Continuum

Jul 8, 2025, 9:07 AM EDT - 7 months ago

Quanterix Completes Acquisition of Akoya Biosciences, Creating the First Integrated Platform Capable of Measuring Biomarkers Across the Blood and Tissue Continuum

Quanterix Expands Reach with IVD and Large Reference Labs

Jun 23, 2025, 7:30 AM EDT - 7 months ago

Quanterix Expands Reach with IVD and Large Reference Labs

Kent Lake Condemns Quanterix's Failure to Schedule Its 2025 Annual Meeting as a Tactic to Silence Shareholders

Jun 11, 2025, 8:00 AM EDT - 8 months ago

Kent Lake Condemns Quanterix's Failure to Schedule Its 2025 Annual Meeting as a Tactic to Silence Shareholders

Quanterix to Present at Goldman Sachs Global Healthcare Conference

Jun 6, 2025, 9:41 AM EDT - 8 months ago

Quanterix to Present at Goldman Sachs Global Healthcare Conference

Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal

May 23, 2025, 2:21 PM EDT - 9 months ago

Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal

AKYA

Quanterix Corporation (QTRX) Q1 2025 Earnings Call Transcript

May 12, 2025, 11:19 PM EDT - 9 months ago

Quanterix Corporation (QTRX) Q1 2025 Earnings Call Transcript

Quanterix Releases Financial Results for the First Quarter of 2025

May 12, 2025, 4:01 PM EDT - 9 months ago

Quanterix Releases Financial Results for the First Quarter of 2025

AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA

May 7, 2025, 3:46 PM EDT - 9 months ago

AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA

AKYA

Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025

May 5, 2025, 7:00 AM EDT - 9 months ago

Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025

Kent Lake Issues Statement on Quanterix's Blatant Disregard for Will of Shareholders

Apr 30, 2025, 8:00 AM EDT - 9 months ago

Kent Lake Issues Statement on Quanterix's Blatant Disregard for Will of Shareholders

AKYA

Quanterix and Akoya Biosciences Announce Amended Merger Agreement

Apr 29, 2025, 7:00 AM EDT - 9 months ago

Quanterix and Akoya Biosciences Announce Amended Merger Agreement

AKYA

Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders

Apr 17, 2025, 8:30 AM EDT - 10 months ago

Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders

Tikvah Management Calls on Quanterix to Explain the Egregious Terms of Convertible Notes Purchased from Akoya Biosciences

Apr 14, 2025, 8:00 AM EDT - 10 months ago

Tikvah Management Calls on Quanterix to Explain the Egregious Terms of Convertible Notes Purchased from Akoya Biosciences

AKYA

Kent Lake Comments on Quanterix's Value Destructive Bridge Financing for Financially Troubled Akoya

Apr 7, 2025, 8:15 AM EDT - 10 months ago

Kent Lake Comments on Quanterix's Value Destructive Bridge Financing for Financially Troubled Akoya

AKYA

Quanterix Showcases Innovation Powered by Simoa® at AD/PD with Customer Research and New Dried Blood Spot Extraction Kit

Apr 1, 2025, 1:00 AM EDT - 10 months ago

Quanterix Showcases Innovation Powered by Simoa® at AD/PD with Customer Research and New Dried Blood Spot Extraction Kit

Tikvah Management Announces Intention to Vote AGAINST Quanterix's Proposed Merger with Akoya Biosciences

Mar 24, 2025, 8:00 AM EDT - 11 months ago

Tikvah Management Announces Intention to Vote AGAINST Quanterix's Proposed Merger with Akoya Biosciences

AKYA

Quanterix Corporation (QTRX) Q4 2024 Earnings Call Transcript

Mar 17, 2025, 7:19 PM EDT - 11 months ago

Quanterix Corporation (QTRX) Q4 2024 Earnings Call Transcript

Quanterix Releases Financial Results for the Fourth Quarter of 2024

Mar 17, 2025, 4:01 PM EDT - 11 months ago

Quanterix Releases Financial Results for the Fourth Quarter of 2024

Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today's Earnings Call

Mar 17, 2025, 4:00 PM EDT - 11 months ago

Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today's Earnings Call

AKYA

Quanterix To Report Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025

Mar 13, 2025, 1:00 PM EDT - 11 months ago

Quanterix To Report Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025

Kent Lake Issues Investor Presentation Detailing Opposition to Quanterix's Proposed Merger with Akoya Biosciences

Mar 11, 2025, 8:00 AM EDT - 11 months ago

Kent Lake Issues Investor Presentation Detailing Opposition to Quanterix's Proposed Merger with Akoya Biosciences

AKYA

Kent Lake Nominates Three Highly Qualified, Independent Candidates for Quanterix Board

Mar 3, 2025, 8:00 AM EST - 11 months ago

Kent Lake Nominates Three Highly Qualified, Independent Candidates for Quanterix Board

Quanterix Highlights Compelling Benefits of Akoya Biosciences Acquisition

Mar 3, 2025, 6:00 AM EST - 11 months ago

Quanterix Highlights Compelling Benefits of Akoya Biosciences Acquisition

The Schall Law Firm Invites Shareholders With Losses In Quanterix Corporation To Join A Securities Fraud Investigation

Mar 2, 2025, 11:00 AM EST - 11 months ago

The Schall Law Firm Invites Shareholders With Losses In Quanterix Corporation To Join A Securities Fraud Investigation

Neurogen Biomarking Announces Global Agreement with Quanterix for Use of Blood Biomarker Assay in its Patient-Initiated Blood Test to Support Early Detection of Dementia and Mild Cognitive Impairment Due to Alzheimer's Disease

Feb 19, 2025, 8:30 AM EST - 1 year ago

Neurogen Biomarking Announces Global Agreement with Quanterix for Use of Blood Biomarker Assay in its Patient-Initiated Blood Test to Support Early Detection of Dementia and Mild Cognitive Impairment Due to Alzheimer's Disease

Kent Lake Issues Letter to Quanterix Shareholders Regarding Opposition to the Company's Proposed Merger with Akoya Biosciences

Feb 18, 2025, 3:40 PM EST - 1 year ago

Kent Lake Issues Letter to Quanterix Shareholders Regarding Opposition to the Company's Proposed Merger with Akoya Biosciences

AKYA

Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Feb 14, 2025, 5:48 PM EST - 1 year ago

Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Quanterix Investor News: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Feb 5, 2025, 3:43 PM EST - 1 year ago

Quanterix Investor News: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

The Schall Law Firm Invites Shareholders With Losses To Join An Investigation Into Quanterix Corporation For Securities Fraud

Feb 1, 2025, 11:00 AM EST - 1 year ago

The Schall Law Firm Invites Shareholders With Losses To Join An Investigation Into Quanterix Corporation For Securities Fraud

IOMASS
IOMASS Jan. 27 at 7:11 PM
$QTRX Interesting trading volume today - down a bit with market but constructive...
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 24 at 12:22 AM
$QTRX Share Price: $6.49 Contract Selected: Aug 21, 2026 $10 Calls Buy Zone: $0.58 – $0.72 Target Zone: $1.06 – $1.29 Potential Upside: 72% ROI Time to Expiration: 209 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Swick02
Swick02 Jan. 23 at 6:56 PM
$QTRX price is back down to where it was before the new CEO announcement. We also learned that revenues and the cash position are both above forecast for year end. Adding more exposure here on this pullback.
0 · Reply
sakuzoh
sakuzoh Jan. 21 at 2:01 PM
$QTRX huge news https://www.stocktitan.net/news/QTRX/quanterix-announces-landmark-jama-study-highlighting-prognostic-sdqbd9t29qvi.html
0 · Reply
IOMASS
IOMASS Jan. 15 at 6:59 PM
$QTRX Don't need an activist at this stage as it appears QTRX is now positioned for growth/enhancing shareholder value but a smart guy entering the picture based on the new changes would help with credibility...
0 · Reply
OMM22
OMM22 Jan. 14 at 7:34 PM
$QTRX ok 👍🏼
0 · Reply
OMM22
OMM22 Jan. 14 at 7:02 PM
$QTRX helloooooooooooooooooooo
0 · Reply
WycklyTrades
WycklyTrades Jan. 13 at 5:33 AM
$QTRX Potential trend reversal with new President/CEO announcement. ($BTU) DCB watch: $NBY $ATEC $INBS
0 · Reply
topstockalerts
topstockalerts Jan. 12 at 9:31 PM
After Hours Top Gainers PT2 $DRCT $BGMS $FBLG $LVLU $QTRX
0 · Reply
sakuzoh
sakuzoh Jan. 12 at 4:37 PM
$QTRX just got into it, new ceo, insider buys, raised guidance. They tick a lot of boxes. Anyone heavy on this stock ?
0 · Reply
OMM22
OMM22 Jan. 12 at 3:18 PM
$QTRX i was right strange stock dumping hard
0 · Reply
Sw1ngb0t
Sw1ngb0t Jan. 10 at 6:31 PM
$QTRX $9.43+
0 · Reply
GSP
GSP Jan. 10 at 5:59 PM
$QTRX makes the watch list for next week. .
0 · Reply
GSP
GSP Jan. 10 at 5:17 PM
$QTRX $MNTS $USAR $UAMY $FJET
0 · Reply
Sw1ngb0t
Sw1ngb0t Jan. 9 at 11:12 PM
$VCIG $MREO $QTRX $CGON $SOWG guaranteed continuation (soon)
0 · Reply
MikeCaymanTrades
MikeCaymanTrades Jan. 9 at 8:06 PM
https://www.youtube.com/watch?v=hzBZQXwr5Yo $QTRX
0 · Reply
OMM22
OMM22 Jan. 9 at 7:30 PM
$QTRX cashed out what a strange stock 😬😬😬😬😬
1 · Reply
topstockalerts
topstockalerts Jan. 9 at 6:28 PM
$QTRX Is it going higher? Comment below..
1 · Reply
WOLFSTREET
WOLFSTREET Jan. 9 at 6:21 PM
$QTRX Stay the course..., CC9.5 (new for 2026) is your shield!
0 · Reply
OMM22
OMM22 Jan. 9 at 5:59 PM
$QTRX 5th in the winners list but NOT moving price target 9 or 10 was today 🚀🚀🚀🚀🚀strange
0 · Reply
topstockalerts
topstockalerts Jan. 9 at 5:56 PM
Top Gainers PT2 $LRHC $QTRX $CGON $OPTX $MRNO
0 · Reply
Will2ride1
Will2ride1 Jan. 9 at 3:57 PM
$QTRX ✅️
0 · Reply